Ghent University Academic Bibliography

Advanced

A randomized, double-blind study comparing twenty-four-week treatment with recombinant interferon-gamma versus placebo in the treatment of rheumatoid arthritis.

Eric Veys, CJ MENKES and P EMERY (1997) ARTHRITIS AND RHEUMATISM. 40(1). p.62-68
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
journal title
ARTHRITIS AND RHEUMATISM
Arthritis Rheum.
volume
40
issue
1
pages
62-68 pages
Web of Science type
Article
ISSN
0004-3591
language
English
UGent publication?
yes
classification
A1
id
181742
handle
http://hdl.handle.net/1854/LU-181742
date created
2004-01-14 13:41:00
date last changed
2016-12-19 15:38:48
@article{181742,
  author       = {Veys, Eric and MENKES, CJ and EMERY, P},
  issn         = {0004-3591},
  journal      = {ARTHRITIS AND RHEUMATISM},
  language     = {eng},
  number       = {1},
  pages        = {62--68},
  title        = {A randomized, double-blind study comparing twenty-four-week treatment with recombinant interferon-gamma versus placebo in the treatment of rheumatoid arthritis.},
  volume       = {40},
  year         = {1997},
}

Chicago
Veys, Eric, CJ MENKES, and P EMERY. 1997. “A Randomized, Double-blind Study Comparing Twenty-four-week Treatment with Recombinant Interferon-gamma Versus Placebo in the Treatment of Rheumatoid Arthritis.” Arthritis and Rheumatism 40 (1): 62–68.
APA
Veys, E., MENKES, C., & EMERY, P. (1997). A randomized, double-blind study comparing twenty-four-week treatment with recombinant interferon-gamma versus placebo in the treatment of rheumatoid arthritis. ARTHRITIS AND RHEUMATISM, 40(1), 62–68.
Vancouver
1.
Veys E, MENKES C, EMERY P. A randomized, double-blind study comparing twenty-four-week treatment with recombinant interferon-gamma versus placebo in the treatment of rheumatoid arthritis. ARTHRITIS AND RHEUMATISM. 1997;40(1):62–8.
MLA
Veys, Eric, CJ MENKES, and P EMERY. “A Randomized, Double-blind Study Comparing Twenty-four-week Treatment with Recombinant Interferon-gamma Versus Placebo in the Treatment of Rheumatoid Arthritis.” ARTHRITIS AND RHEUMATISM 40.1 (1997): 62–68. Print.